BioXtreme secures $15M for neurorehabilitation scaling
CEO Eyal Samuel Shachar shares future plans. Intelligent challenges drive real recovery.
See the latest news and media coverage for Bioxtreme. We track all announcements, press releases, and industry mentions in real time, all in one place.
Rehabilitation robotics for stroke neurotherapy
bio-xtreme.comLast updated
In short: Bioxtreme secured $15 million in strategic funding, launched its Plaxtreme robotic rehabilitation solution, and expanded its global leadership team.
CEO Eyal Samuel Shachar shares future plans. Intelligent challenges drive real recovery.
The investment from Serra Holding fuels U.S. and Europe expansion. They strengthen leadership, add advisors, and launch Plaxtreme robotic rehab solution.
It features advanced grasp and release training with supination, pronation, and patented Error Augmentation technology for upper-limb rehabilitation. View at AOTA Inspire 2026 Booth 329.
It uses AI-driven Error Augmentation for upper-limb therapy. Experience it at ESPRM 2026 Booth 4 starting Monday.
Dextreme 2.0 combines patented Error Augmentation technology, adaptive AI and immersive therapy to accelerate motor recovery after neurological injury Bioxtreme Launches Next Generation Dextreme™ System...
Chicago, IL, April 21, 2026 (GLOBE NEWSWIRE)-- Bioxtreme, an innovator in neurorehabilitation technologies leveraging its proprietary error augmentation approach to ...
Report Ocean publicize new report on the global Rehabilitation Robots market. The global Rehabilitation Robots market report contains numerous information about factors, such as market...
Track Bioxtreme and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Bioxtreme and other trending companies.